CORRECTION article

Front. Pharmacol., 08 September 2022

Sec. Inflammation Pharmacology

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.971840

Corrigendum: Circadian rhythm protein Bmal1 modulates cartilage gene expression in temporomandibular joint osteoarthritis via the MAPK/ERK pathway

  • 1. Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China

  • 2. Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, China

  • 3. Department of Plastic Surgery, Jinan Airong Plastic Surgery Hospital, Jinan, China

In the published article, there was an error in Figures 3, 4 as published. In Figure 3, the Western blot result of IL-6 was selected incorrectly. In Figure 4, images from Figure 5B were accidentally repeated in Figure 4B. The corrected Figures 3, 4 appear below.

FIGURE 3

FIGURE 4

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

circadian rhythm disturbance, osteoarthritis, temporomandibular joint, BMAL-1, cartilage, interleukin-6, MAPK/ERK pathway

Citation

Chen G, Zhao H, Ma S, Chen L, Wu G, Zhu Y, Zhu J, Ma C and Zhao H (2022) Corrigendum: Circadian rhythm protein Bmal1 modulates cartilage gene expression in temporomandibular joint osteoarthritis via the MAPK/ERK pathway. Front. Pharmacol. 13:971840. doi: 10.3389/fphar.2022.971840

Received

17 June 2022

Accepted

25 July 2022

Published

08 September 2022

Volume

13 - 2022

Edited and reviewed by

Emanuela Ricciotti, University of Pennsylvania, United States

Updates

Copyright

*Correspondence: Chuan Ma, ; Huaqiang Zhao,

This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics